1Zimmerman. Sulfonylureas. Endocrinol Metab Clin North Am 1997;6(3):511.
2Bressler R, Johnson DG, Pharmacological regulation of blood glucose levels in Non - insulin - dependent diabetes mellitus. Arch Intern Med 1997;157(4) :836.
3UK Prospective Diabetes Study Group: Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS 33).Lancet 1998;352:837.
4Owens DR. Repalinide - Prandial glucose regulator: a new class of oral diabetic durgs. Diabet Med 1998; 15: s28.
5Bell PM, Hadden DR. Metformin. Endocrinol Metab Clin North Am 1997;6(3) :523.
6Edelman SV. New oral antidiabetic agents for the prevention and managment of NIDDM. International Diabetes Monitor 1996;8(4): 1.
7UK Prospective Diabetes Study Group. Effect of intensive blood - glucose control with metformin on complications in over -weight patients with type 2 diabetes(UKPDS 34). lancet 1998;352:854.
8Lebovitz HZ. Alpha - glucosidase inhibitors. Endocrinol Metab Clin North Am 1997;6(3):539.
9Bayraktar M, Van THiel DH, Adalar N. A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea - treated NIDDM patients. Diabetes Care 1996; 19(3) :252.
10Henry RR. Thiazolinediones Endocrinol Metabol Clin North Am 1997;26()3. :553
